Vaxart, Inc. (VXRT)
0.5747
-0.02
(-2.58%)
USD |
OTCM |
Feb 11, 16:00
Vaxart Total Liabilities (Quarterly) : 182.23M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Bionano Genomics, Inc. | 29.26M |
| Agenus, Inc. | 514.76M |
| Curis, Inc. | 42.33M |
| LadRx Corp. | 2.395M |
| Plus Therapeutics, Inc. | 13.62M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 208.99M |
| Shareholders Equity (Quarterly) | 26.76M |
| Debt to Equity Ratio | 0.7086 |
| Current Ratio | 0.6933 |
| Net Debt Paydown Yield | 1.00% |